Barclays Reiterates an 'Overweight/Top Pick' on Bed Bath & Beyond (BBBY); Q4 Preview: Expect Strong Showing

Barclays reiterates an 'Overweight' on Bed Bath & Beyond (NASDAQ: BBBY) price target of $70.00.

Analyst, Alan M. Rifkin, said, "Our 4Q11 EPS estimate of $1.35 is driven by continued fundamental strength and is above the high end of management guidance of $1.28 - $1.33. Our estimate is also $0.03 above consensus expectations. In our view, strong holiday sales in December kicked off the quarter and continued throughout 4Q. We reiterate our 4Q same-store sales
forecast of 4.5%, an estimate we initiated in December."

For an analyst ratings summary and ratings history on Bed Bath & Beyond click here. For more ratings news on Bed Bath & Beyond click here.

Shares of Bed Bath & Beyond closed at $67.23 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Piper Sandler Reiterates Overweight Rating on Estee Lauder (EL), 'F4Q26 Preview'
• KinderCare Learning Companies (KLC) PT Lowered to $4.50 at UBS
• SoundThinking (SSTI) PT Lowered to $8 at Cantor Fitzgerald